Status: Finalised
First registered on:
01/02/2016
Last updated on:
23/03/2018
1. Study identification
EU PAS Register NumberEUPAS12241
Official titleDrug utilisation study (DUS) on flupirtine-containing medicinal products
Study title acronym
Study typeOther: Retrospective Database Analysis
Brief description of the studyRetrospective drug utilisation study using patient-level databases to characterise prescribing practice of flupirtine-containing medicinal products during routine clinical use and assess the main reasons for prescription by representative groups of prescribers
Was this study requested by a regulator?Yes: EMA
Is the study required by a Risk Management Plan (RMP)?
EU RMP category 1 (imposed as condition of marketing authorisation)
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsIMS Health
Department/Research groupReal World Evidence Solutions
Organisation/affiliationIMS Health
Details of (Primary) lead investigator
Title Professor
Last name Kostev
First name Karel
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)
Countries in which this study is being conducted
National study
Germany
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed22/09/201502/11/2015
Start date of data collection02/11/201502/11/2015
Start date of data analysis09/11/201509/11/2015
Date of interim report, if expected
Date of final study report29/02/201625/02/2016
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesLupin100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Mrs
Last name Dombrowski
First name Silvia
Address line 1Darmstädter Landstr. 108
Address line 2
Address line 3
CityFrankfurt
Postcode60598
CountryGermany
Phone number (incl. country code)49-69-66044765
Alternative phone number
Fax number (incl. country code)
Public Enquiries
Title Professor
Last name Kostev
First name Karel
Address line 1Darmstädter Landstr. 108
Address line 2
Address line 3
CityFrankfurt
Postcode60598
CountryGermany
Phone number (incl. country code)49-69-66044878
Alternative phone number
Fax number (incl. country code)
6. Study drug(s) information
Substance class (ATC Code)N02BG07 (flupirtine)
7. Medical conditions to be studied
Medical condition(s)No
8. Population under study
Age
Adolescents (12 - 17 years)
Adults (18 - 44 years)
Adults (45 - 64 years)
Adults (65 - 74 years)
Adults (75 years and over)
Sex
Male
Female
9. Number of subjects
Estimated total number of subjects10000
Additional information
1. Two specialty Groups: genereral practicioners and orthopaedist, together and seperately analysed
2. Each Group split to incident and prevalent subgroup of patients, and also as total analysed
10. Source of data
Is this study being carried out with an established data source?Yes
Data sources not registered with ENCePP
IMS Disease Analyzer, Germany
Sources of data
Routine primary care electronic patient registry
11. Scope of the study
What is the scope of the study?
Drug utilisation study
Primary scope : Drug utilisation study
12. Main objective(s)
What is the main objective of the study?
Assessment of prescribing and Treatment Patterns of flupirtine-containing medical products during Routine use in the out Patient Settings before and after the Revision of SmPC.
Are there primary outcomes?Yes
- Main reason for prescription
- Amount of patients contraindicated for the use of NSAIDs/weak Opioids
- Treatment Duration
- Share of single/repeated prescriptions
- Lenght of Treatment episodes
- Amount of Liver Function Test
- Concomitant Treatment and diseases
Are there secondary outcomes?No
13. Study design
What is the design of the study?
Drug utilisation study
14. Follow-up of patients
Will patients be followed up?Not applicable/no follow-up
15. Data analysis plan
Please provide a brief summary of the analysis method
Descriptive Analysis showing Treatment Patterns and main reason for prescription.
No statistical testing.
Data source is represetative IMS Disease Analyzer database Panel General practicioner and orhtopaedists.
16. ENCePP seal
Are you requesting the ENCePP seal for this study?
No
17. Full protocol
18. Study Results
Please list the 5 most relevant publications using data from your study
ReferenceLink to web-publication
None
19. Other relevant documents
Conflict(s) of interest of
investigator(s)Not submitted
Composition of Steering Group and
ObserversNot submitted
Other documentsNot
submitted
Signed Code of
Conduct Checklist
Not submitted
Signed Code of Conduct Declaration
Not submitted
Signed Checklist for Study
Protocols
Not submitted
